[The biochemical basis of the complications of diabetes].
作者信息
Gabbay K H
出版信息
Journ Annu Diabetol Hotel Dieu. 1984:307-20.
PMID:6443221
Abstract
摘要
相似文献
1
[The biochemical basis of the complications of diabetes].[糖尿病并发症的生化基础]
Journ Annu Diabetol Hotel Dieu. 1984:307-20.
2
[Sorbitol route of glucose metabolism and complication of diabetes mellitus].[葡萄糖代谢的山梨醇途径与糖尿病并发症]
Probl Endokrinol (Mosk). 1980 May-Jun;26(3):86-90.
3
Polyol pathway in the pathogenesis of diabetic complications and aldose reductase inhibitors.糖尿病并发症发病机制中的多元醇途径及醛糖还原酶抑制剂
J Assoc Physicians India. 1992 Oct;40(10):679-81.
4
[Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].醛糖还原酶抑制剂的临床应用——糖尿病并发症的防治
Nihon Rinsho. 1987 Dec;45(12):3010-27.
5
[Sorbitol pathway of glucose metabolism in streptozotocin diabetes of varying duration and severity].[不同病程和严重程度的链脲佐菌素糖尿病中葡萄糖代谢的山梨醇途径]
Probl Endokrinol (Mosk). 1984 Mar-Apr;30(2):71-6.
6
Etiology of cataracts in diabetics.糖尿病患者白内障的病因
Int Ophthalmol Clin. 1984 Winter;24(4):93-110.
7
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.醛糖还原酶抑制剂：一类用于某些糖尿病并发症药物控制的潜在新型药物。
J Med Chem. 1985 Jul;28(7):841-9. doi: 10.1021/jm00145a001.
8
Aldose reductase in diabetic cataracts.糖尿病性白内障中的醛糖还原酶。
JAMA. 1981 Jul 17;246(3):257-61.
9
The effect of aldose reductase and its inhibition on sugar cataract formation.醛糖还原酶的作用及其抑制对糖性白内障形成的影响。
Metabolism. 1986 Apr;35(4 Suppl 1):15-9. doi: 10.1016/0026-0495(86)90181-2.
10
Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.链脲佐菌素诱导的糖尿病大鼠中醛糖还原酶和山梨醇脱氢酶抑制剂对神经血管功能、神经传导及组织多元醇途径代谢产物影响的比较
Diabetologia. 1997 Mar;40(3):271-81. doi: 10.1007/s001250050674.
Zotero 插件